Medical Supervision Required : Both medications require a prescription and ongoing medical monitoring to ensure safety and effectiveness
Stocklein W., Sztajer H., Menge U
Image Credit: Alones / Shutterstock In a recent proof-of-concept study published in the journal eClinicalMedicine , researchers in Denmark describe the safety and efficacy outcomes of the first human trial of Dapiglutide, a novel drug that targets both the glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) receptors
Tune in here: #loveinscience #teamfirst #podcast To view or add a comment, sign in I strongly recommend Benjamins podcast to anyone stepping into leadership roles within small biopharma start-ups
Always share this with your healthcare provider before starting treatment
Les radicaux libres et le stress oxydatif endommagent non seulement les protines, mais attaquent galement l'ADN, entranant des mutations gntiques, voire des cancers